Angelo M. De Marzo mainly investigates Prostate cancer, Prostate, Pathology, Cancer and Cancer research. His research in Prostate cancer intersects with topics in Immunology and PTEN. His Prostate study incorporates themes from Carcinogenesis, Inflammation, Lymph node and Small-cell carcinoma.
His Pathology research integrates issues from Telomere and Adenocarcinoma. His work on Tissue microarray, Metastasis and Androgen receptor is typically connected to TMPRSS2 as part of general Cancer study, connecting several disciplines of science. Angelo M. De Marzo focuses mostly in the field of Cancer research, narrowing it down to matters related to Disease and, in some cases, Epidemiology, Chronic infection and Pathological.
Angelo M. De Marzo mostly deals with Prostate cancer, Prostate, Cancer research, Internal medicine and Pathology. Cancer covers he research in Prostate cancer. He has included themes like Biopsy and Immunology in his Prostate study.
The Cancer research study combines topics in areas such as DNA methylation, Cancer cell, Molecular biology, Metastasis and Androgen receptor. In his work, Disease and Single-nucleotide polymorphism is strongly intertwined with Oncology, which is a subfield of Internal medicine. He combines subjects such as Fluorescence in situ hybridization and Adenocarcinoma with his study of Pathology.
His primary areas of study are Prostate cancer, Prostate, Cancer research, Internal medicine and Cancer. His Prostate cancer study integrates concerns from other disciplines, such as Inflammation, Metastasis, PTEN and Pathology. His Metastasis research incorporates elements of Biochemical recurrence and Tumor progression.
His work deals with themes such as Telomere, Stromal cell, Tissue microarray and Immunophenotyping, which intersect with Prostate. His study focuses on the intersection of Cancer research and fields such as Immunotherapy with connections in the field of CD8. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology.
Angelo M. De Marzo focuses on Prostate cancer, Prostate, Cancer research, Cancer and Pathology. His Prostate cancer research includes elements of Metastasis, PTEN and Tissue microarray. To a larger extent, Angelo M. De Marzo studies Internal medicine with the aim of understanding Prostate.
His biological study spans a wide range of topics, including Hormone therapy, Carcinoma, Gene knockdown and Gene mutation. His research integrates issues of Immunohistochemistry, Regulation of gene expression, Prospective cohort study and Biopsy in his study of Cancer. His work carried out in the field of Pathology brings together such families of science as Germline mutation, Somatic hypermutation and Primary Gleason Pattern.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Overexpression of Hypoxia-inducible Factor 1α in Common Human Cancers and Their Metastases
Hua Zhong;Angelo M. De Marzo;Erik Laughner;Michael Lim.
Cancer Research (1999)
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Emmanuel S. Antonarakis;Changxue Lu;Hao Wang;Brandon Luber.
The New England Journal of Medicine (2014)
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.
Ping Gao;Irina Tchernyshyov;Tsung Cheng Chang;Yun Sil Lee.
Nature (2009)
Inflammation in prostate carcinogenesis
Angelo M. De Marzo;Angelo M. De Marzo;Elizabeth A. Platz;Siobhan Sutcliffe;Jianfeng Xu.
Nature Reviews Cancer (2007)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Jacques Lapointe;Chunde Li;John P. Higgins;Matt van de Rijn.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Proliferative Inflammatory Atrophy of the Prostate : Implications for Prostatic Carcinogenesis
Angelo M. De Marzo;Valerie L. Marchi;Jonathan I. Epstein;William G. Nelson.
American Journal of Pathology (1999)
α-methylacyl-CoA racemase: A new molecular marker for prostate cancer
Jun Luo;Shan Zha;Wesley R. Gage;Thomas A. Dunn.
Cancer Research (2002)
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
Jonathan W Simons;Bahar Mikhak;Ju-Fay Chang;Angelo M DeMarzo.
Cancer Research (1999)
Pathological and molecular aspects of prostate cancer.
Angelo M DeMarzo;William G Nelson;William B Isaacs;Jonathan I Epstein.
The Lancet (2003)
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.
J. Carpten;N. Nupponen;S. Isaacs;R. Sood.
Nature Genetics (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University School of Medicine
Johns Hopkins University
Johns Hopkins University
University of Alabama at Birmingham
Johns Hopkins University
Columbia University
Johns Hopkins University
Johns Hopkins University
The University of Texas Health Science Center at San Antonio
Johns Hopkins University School of Medicine
Dalian University of Technology
Yale University
University of California, Berkeley
SLAC National Accelerator Laboratory
Chalmers University of Technology
Vanda Pharmaceuticals (United States)
Panjab University
University of California, Davis
Heidelberg University
Batavia Biosciences (Netherlands)
Japan Agency for Marine-Earth Science and Technology
Loughborough University
University of Eastern Finland
University of Kansas
Kyoto University
University of Minnesota